These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 30583006)

  • 21. Absence of YF-neutralizing antibodies in vulnerable populations of Brazil: A warning for epidemiological surveillance and the potential risks for future outbreaks.
    Stoffella-Dutra AG; Silva de Oliveira J; Barbosa Costa G; Geessien Kroon E; Santos Abrahão J; Desiree LaBeaud A; Paiva Drumond B; Bretas de Oliveira D; de Souza Trindade G
    Vaccine; 2020 Sep; 38(42):6592-6599. PubMed ID: 32788140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outbreak of Yellow Fever among Nonhuman Primates, Espirito Santo, Brazil, 2017.
    Fernandes NCCA; Cunha MS; Guerra JM; Réssio RA; Cirqueira CDS; Iglezias SD; de Carvalho J; Araujo ELL; Catão-Dias JL; Díaz-Delgado J
    Emerg Infect Dis; 2017 Dec; 23(12):2038-2041. PubMed ID: 29148378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection and Molecular Characterization of Yellow Fever Virus, 2017, Brazil.
    Figueiredo PO; Silva ATS; Oliveira JS; Marinho PE; Rocha FT; Domingos GP; Poblete PCP; Oliveira LBS; Duarte DC; Bonjardim CA; Abrahão JS; Kroon EG; Drumond BP; Oliveira DB; Trindade GS
    Ecohealth; 2018 Dec; 15(4):864-870. PubMed ID: 30117000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Yellow fever epidemiology in Brazil].
    Mondet B
    Bull Soc Pathol Exot; 2001 Aug; 94(3):260-7. PubMed ID: 11681224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Yellow fever in the diagnostics laboratory.
    Domingo C; Charrel RN; Schmidt-Chanasit J; Zeller H; Reusken C
    Emerg Microbes Infect; 2018 Jul; 7(1):129. PubMed ID: 30002363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk assessment of yellow fever urbanization in Rio de Janeiro, Brazil.
    Codeço CT; Luz PM; Struchiner CJ
    Trans R Soc Trop Med Hyg; 2004 Dec; 98(12):702-10. PubMed ID: 15485700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Yellow fever: an emerging threat for Kenya and other east African countries.
    Sanders EJ; Tukei PM
    East Afr Med J; 1996 Jan; 73(1):10-2. PubMed ID: 8625854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Yellow fever outbreak in a rural-urban mixed community of Espírito Santo, Brazil: epidemiological aspects.
    Moussallem TM; Gava C; Ardisson KS; Marques CS; Graceli GC; Koski ADPV; Almada GL; da Silva AR; de Jesus FAA; Rodrigues GAP; da Silva TCC
    Rev Panam Salud Publica; 2019; 43():e29. PubMed ID: 31093253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Yellow fever epizootics in non-human primates, São Paulo state, Brazil, 2008-2009.
    Moreno ES; Spinola R; Tengan CH; Brasil RA; Siciliano MM; Coimbra TL; Silveira VR; Rocco IM; Bisordi I; Souza RP; Petrella S; Pereira LE; Maeda AY; Silva FG; Suzuki A
    Rev Inst Med Trop Sao Paulo; 2013; 55(1):45-50. PubMed ID: 23328725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiological and laboratory characterization of a yellow fever outbreak in northern Uganda, October 2010-January 2011.
    Wamala JF; Malimbo M; Okot CL; Atai-Omoruto AD; Tenywa E; Miller JR; Balinandi S; Shoemaker T; Oyoo C; Omony EO; Kagirita A; Musenero MM; Makumbi I; Nanyunja M; Lutwama JJ; Downing R; Mbonye AK
    Int J Infect Dis; 2012 Jul; 16(7):e536-42. PubMed ID: 22575876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What's Old Is New Again: The Re-emergence of Yellow Fever in Brazil and Vaccine Shortages.
    Chen LH; Kozarsky PE; Visser LG
    Clin Infect Dis; 2019 May; 68(10):1761-1762. PubMed ID: 30204852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential Yellow Fever Susceptibility in New World Nonhuman Primates, Comparison with Humans, and Implications for Surveillance.
    de Azevedo Fernandes NCC; Guerra JM; Díaz-Delgado J; Cunha MS; Saad LD; Iglezias SD; Ressio RA; Dos Santos Cirqueira C; Kanamura CT; Jesus IP; Maeda AY; Vasami FGS; de Carvalho J; de Araújo LJT; de Souza RP; Nogueira JS; Spinola RMF; Catão-Dias JL
    Emerg Infect Dis; 2021 Jan; 27(1):47-56. PubMed ID: 33350931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sero-prevalence of yellow fever and related Flavi viruses in Ethiopia: a public health perspective.
    Mengesha Tsegaye M; Beyene B; Ayele W; Abebe A; Tareke I; Sall A; Yactayo S; Shibeshi ME; Staples E; Belay D; Lilay A; Alemu A; Alemu E; Kume A; H/Mariam A; Ronveaux O; Tefera M; Kassa W; Bekele Weyessa A; Jima D; Kebede A; Tayachew A
    BMC Public Health; 2018 Aug; 18(1):1011. PubMed ID: 30107830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Yellow fever in the Gambia, 1978--1979: epidemiologic aspects with observations on the occurrence of orungo virus infections.
    Monath TP; Craven RB; Adjukiewicz A; Germain M; Francy DB; Ferrara L; Samba EM; N'Jie H; Cham K; Fitzgerald SA; Crippen PH; Simpson DI; Bowen ET; Fabiyi A; Salaun JJ
    Am J Trop Med Hyg; 1980 Sep; 29(5):912-28. PubMed ID: 7435793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reemergence of yellow fever in Ethiopia after 50 years, 2013: epidemiological and entomological investigations.
    Lilay A; Asamene N; Bekele A; Mengesha M; Wendabeku M; Tareke I; Girmay A; Wuletaw Y; Adossa A; Ba Y; Sall A; Jima D; Mengesha D
    BMC Infect Dis; 2017 May; 17(1):343. PubMed ID: 28506254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Review of the risks and benefits of yellow fever vaccination including some new analyses.
    Monath TP
    Expert Rev Vaccines; 2012 Apr; 11(4):427-48. PubMed ID: 22551029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepato-pathological hallmarks for the surveillance of Yellow Fever in South American non-human primates.
    Passos PHO; Ramos DG; Romano AP; Cavalcante KRLJ; Miranda LHM; Coelho JMCO; Barros RC; Martins Filho AJ; Quaresma JAS; Macêdo IL; Wilson TM; Sousa DER; de Melo CB; Castro MB
    Acta Trop; 2022 Jul; 231():106468. PubMed ID: 35429458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical profiles and factors associated with mortality in adults with yellow fever admitted to an intensive care unit in Minas Gerais, Brazil.
    de Ávila RE; José Fernandes H; Barbosa GM; Araújo AL; Gomes TCC; Barros TG; Moreira RLF; Silva GLC; de Oliveira NR
    Int J Infect Dis; 2020 Apr; 93():90-97. PubMed ID: 32004691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Yellow Fever in Africa: estimating the burden of disease and impact of mass vaccination from outbreak and serological data.
    Garske T; Van Kerkhove MD; Yactayo S; Ronveaux O; Lewis RF; Staples JE; Perea W; Ferguson NM;
    PLoS Med; 2014 May; 11(5):e1001638. PubMed ID: 24800812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Yellow fever outbreak affecting Alouatta populations in southern Brazil (Rio Grande do Sul State), 2008-2009.
    de Almeida MA; Dos Santos E; da Cruz Cardoso J; da Fonseca DF; Noll CA; Silveira VR; Maeda AY; de Souza RP; Kanamura C; Brasil RA
    Am J Primatol; 2012 Jan; 74(1):68-76. PubMed ID: 22020690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.